Marshall Wace, LLP Anika Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 16,381 shares of ANIK stock, worth $284,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,381
Previous 27,814
41.11%
Holding current value
$284,210
Previous $704,000
42.61%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ANIK
# of Institutions
123Shares Held
11.5MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.12MShares$36.9 Million5.75% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$27.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$13.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$12.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny574KShares$9.96 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $253M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...